AIP
KYNB

Ameritas Investment Partners’s Kyntra Bio KYNB Stock Holding History

Ameritas Investment Partners’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-282
Closed -$16.6K – 3168
2024
Q1 		$16.6K Hold
282
– – ﹤0.01% 2637
2023
Q4 		$6.25K Hold
282
– – ﹤0.01% 2938
2023
Q3 		$6.09K Hold
282
– – ﹤0.01% 2955
2023
Q2 		$19.1K Hold
282
– – ﹤0.01% 2589
2023
Q1 		$132K Hold
282
– – 0.01% 1346
2022
Q4 		$141K Hold
282
– – 0.01% 1358
2022
Q3 		$91K Hold
282
– – ﹤0.01% 1556
2022
Q2 		$74K Hold
282
– – ﹤0.01% 1709
2022
Q1 		$85K Hold
282
– – ﹤0.01% 1749
2021
Q4 		$100K Hold
282
– – ﹤0.01% 1684
2021
Q3 		$72K Hold
282
– – ﹤0.01% 1904
2021
Q2 		$188K Hold
282
– – 0.01% 1296
2021
Q1 		$245K Hold
282
– – 0.01% 1076
2020
Q4 		$262K Sell
282
-12
-4% -$12.6K 0.01% 992
2020
Q3 		$302K Hold
294
– – 0.01% 868
2020
Q2 		$297K Buy
294
+15
+5% +$13.9K 0.01% 861
2020
Q1 		$242K Buy
279
+8
+3% +$7.95K 0.01% 848
2019
Q4 		$291K Buy
271
+7
+3% +$7.15K 0.01% 905
2019
Q3 		$244K Hold
264
– – 0.01% 954
2019
Q2 		$298K Buy
264
+15
+6% +$16.4K 0.01% 876
2019
Q1 		$339K Hold
249
– – 0.02% 829
2018
Q4 		$288K Hold
249
– – 0.02% 824
2018
Q3 		$379K Hold
249
– – 0.02% 797
2018
Q2 		$390K Buy
249
+11
+5% +$14.3K 0.02% 790
2018
Q1 		$275K Hold
238
– – 0.01% 937
2017
Q4 		$282K Buy
238
+9
+4% +$11.3K 0.01% 915
2017
Q3 		$275K Buy
229
+20
+10% +$21.1K 0.01% 909
2017
Q2 		$169K Buy
209
+28
+15% +$19.5K 0.01% 1148
2017
Q1 		$111K Buy
+181
New +$110K 0.01% 1360

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameritas Investment Partners's KYNB Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 282 shares — an estimated $16.6K sold.

Ameritas Investment Partners first reported a position in KYNB in Q1 2017 and held it in 29 quarters. The position peaked at $390K in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 282 Kyntra Bio shares in Q2 2024, an estimated $16.6K.
  • Ameritas Investment Partners first reported a position in Kyntra Bio in Q1 2017 and held it in 29 quarters.
  • Ameritas Investment Partners's Kyntra Bio position peaked at $390K in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.